We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+21.28%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$2.3B
AUM Growth
+$384M
Cap. Flow
+$216M
Cap. Flow %
9.39%
Top 10 Hldgs %
49.4%
Holding
255
New
116
Increased
33
Reduced
43
Closed
21

Top Buys

Rank Stock Value
1
KSPI icon
Kaspi.kz JSC
KSPI
+$20M
2
MREO
Mereo BioPharma
MREO
+$19.3M
3
BDX icon
Becton Dickinson
BDX
+$17.1M
4
SUNC
SunocoCorp LLC
SUNC
+$11.8M
5
MOH icon
Molina Healthcare
MOH
+$8.88M

Top Sells

Rank Stock Value
1
WDC icon
Western Digital
WDC
+$29.7M
2
QURE icon
uniQure
QURE
+$26.4M
3
LLY icon
Eli Lilly
LLY
+$21.8M
4
BBIO icon
BridgeBio Pharma
BBIO
+$19.6M
5
SNDK
Sandisk
SNDK
+$16.4M

Sector Composition

Rank Sector Weight
1 Healthcare 21.71%
2 Financials 6.94%
3 Consumer Discretionary 6.7%
4 Industrials 3.7%
5 Technology 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLTR icon
1
PUT
Palantir
PLTR
$295B
$414M 18.01%
2,328,700
+1,194,600
+105% +$216M
LLY icon
2
PUT
Eli Lilly
LLY
$1.07T
$166M 7.2%
154,000
+4,000
+3% +$3.82M
TSLA icon
3
PUT
Tesla
TSLA
$1.24T
$94.4M 4.11%
210,000
-500
-0.2% -$222K
NVDA icon
4
PUT
NVIDIA
NVDA
$5.01T
$85M 3.7%
+456,000
New +$84.9M
COF icon
5
Capital One
COF
$124B
$81.2M 3.53%
335,000
+10,000
+3% +$2.23M
WVE icon
6
Wave Life Sciences
WVE
$1.12B
$68.3M 2.97%
4,015,000
-135,000
-3% -$1.37M
CVNA icon
7
Carvana
CVNA
$43.3B
$63.3M 2.75%
750,000
– –
MDGL icon
8
PUT
Madrigal Pharmaceuticals
MDGL
$12.6B
$57.7M 2.51%
99,000
-53,000
-35% -$27.1M
ALNY icon
9
PUT
Alnylam Pharmaceuticals
ALNY
$36.3B
$56.1M 2.44%
141,100
+5,400
+4% +$2.39M
PRAX icon
10
PUT
Praxis Precision Medicines
PRAX
$9.07B
$50M 2.18%
+169,800
New +$31.6M
GXO icon
11
GXO Logistics
GXO
$6.06B
$36.1M 1.57%
685,000
-90,000
-12% -$4.73M
HGV icon
12
Hilton Grand Vacations
HGV
$3.84B
$33.3M 1.45%
745,000
+120,000
+19% +$5.1M
PTGX icon
13
Protagonist Therapeutics
PTGX
$8.75B
$33.2M 1.45%
380,669
-26,831
-7% -$2.2M
ANAB icon
14
AnaptysBio
ANAB
$1.6B
$31.4M 1.37%
648,093
+101,093
+18% +$3.94M
UWMC icon
15
UWM Holdings
UWMC
$621M
$30.9M 1.34%
7,050,518
-349,482
-5% -$1.88M
PHAT icon
16
Phathom Pharmaceuticals
PHAT
$912M
$29.6M 1.29%
1,785,000
-35,380
-2% -$505K
WDC icon
17
Western Digital
WDC
$179B
$24.7M 1.07%
143,300
-195,700
-58% -$29.7M
IONQ icon
18
PUT
IonQ
IONQ
$12.3B
$24.4M 1.06%
544,200
+339,200
+165% +$19M
AMTM
19
Amentum Holdings
AMTM
$5.51B
$24.2M 1.05%
835,000
-440,000
-35% -$11.2M
MOH icon
20
Molina Healthcare
MOH
$10.3B
$23.4M 1.02%
135,000
+54,000
+67% +$8.88M
KSPI icon
21
Kaspi.kz JSC
KSPI
$16.3B
$20.7M 0.9%
+265,000
New +$20M
MGTX icon
22
MeiraGTx Holdings
MGTX
$1.09B
$20.3M 0.89%
2,559,082
-65,918
-3% -$548K
AMLX icon
23
Amylyx Pharmaceuticals
AMLX
$2.05B
$19.9M 0.87%
1,650,000
-110,000
-6% -$1.49M
NVO
24
PUT
Novo Nordisk
NVO
$216B
$19M 0.83%
374,200
-225,000
-38% -$11.5M
COF icon
25
PUT
Capital One
COF
$124B
$18.2M 0.79%
75,000
– –
1
2 3 4 5

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, 683 Capital Management held 255 positions worth $2.3B, up 20% from $1.91B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

683 Capital Management deployed $216M of net new capital in Q4 2025, opening 116 new positions and adding to 33 existing holdings. Its largest new stake was Kaspi.kz JSC: 265,000 shares worth $20.7M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Western Digital, an estimated $29.7M trimmed.

  • 683 Capital Management's largest Q4 2025 buy was Kaspi.kz JSC: 265,000 shares worth $20.7M.
  • 683 Capital Management added most to Mereo BioPharma in Q4 2025, an estimated $19.3M increase.
  • 683 Capital Management's biggest Q4 2025 reduction was Western Digital, cutting an estimated $29.7M.
  • 683 Capital Management fully exited Eli Lilly in Q4 2025, selling an estimated $21.8M.
  • 683 Capital Management's ten largest holdings make up 49% of its $2.3B portfolio in Q4 2025.
  • 683 Capital Management opened 116 new positions and closed 21 in Q4 2025.
  • 683 Capital Management's portfolio value rose 20% quarter-over-quarter to $2.3B.

Based on 683 Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.